ELB-245

N/A

Report date: 2023/02/11 20:37:59
NME

Base Information

Drug NameELB-245
Drug Alias NameELB-245
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsUrinary IncontinenceUrinary Bladder, Overactive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenPolandGermany
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesElbion
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesElbion Ag
Active IndicationsN/A
Inactive IndicationsUrinary IncontinenceUrinary Bladder, Overactive

Other Information

ATC CodeN/A
Related LinksN/A